missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Quinolines and derivatives
  7. Dihydroergotamine Mesylate 97.0+%, TCI America™

Dihydroergotamine Mesylate 97.0+%, TCI America™

$153.06 - $557.48

Chemical Identifiers

CAS 6190-39-2
Molecular Formula C34H41N5O8S
Molecular Weight (g/mol) 679.79
MDL Number MFCD00058615
InChI Key ADYPXRFPBQGGAH-UMYZUSPBSA-N
Synonym dihydroergotamine mesylate, dihydroergotamine methanesulfonate salt, dihydroergotoxine, prestwick_746, dihydroergotamine methanesulfonate salt, powder, dihydroergotamine mesilate, european pharmacopoeia ep reference standard, dihydroergotamine for peak identification, european pharmacopoeia ep reference standard, dihydroergotamine mesylate, united states pharmacopeia usp reference standard, 4r,7r-n-1s,2s,4r,7s-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo 7.3.0.0^ 2,6 dodecan-4-yl-6-methyl-6,11-diazatetracyclo 7.6.1.0^ 2,7 .0^ 12,16 hexadeca-1 15 ,9,12 16 ,13-tetraene-4-carboxamide; methanesulfonic acid, 6ar,9r-n-2r,5s,10as,10bs-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8h-oxazolo 3,2-a pyrrolo 2,1-c pyrazin-2-yl-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo 4,3-fg quinoline-9-carboxamide methanesulfonate
PubChem CID 6420006
IUPAC Name (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid
SMILES CS(O)(=O)=O.CN1C[C@@H](C[C@H]2[C@H]1CC1=CNC3=CC=CC2=C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3=CC=CC=C3)N2C1=O
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity  
Catalog Number Mfr. No. Quantity Price Quantity  
D2633100MG
View Documents
View Product Certificates
TCI America
D2633100MG 		100 mg
Each for $153.06
Only null left
 
D26331G
View Documents
View Product Certificates
TCI America
D26331G 		1 g
Each for $557.48
Only null left
 
Description

Description

Specifications

Chemical Identifiers

6190-39-2
679.79
ADYPXRFPBQGGAH-UMYZUSPBSA-N
6420006
CS(O)(=O)=O.CN1C[C@@H](C[C@H]2[C@H]1CC1=CNC3=CC=CC2=C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3=CC=CC=C3)N2C1=O
C34H41N5O8S
MFCD00058615
dihydroergotamine mesylate, dihydroergotamine methanesulfonate salt, dihydroergotoxine, prestwick_746, dihydroergotamine methanesulfonate salt, powder, dihydroergotamine mesilate, european pharmacopoeia ep reference standard, dihydroergotamine for peak identification, european pharmacopoeia ep reference standard, dihydroergotamine mesylate, united states pharmacopeia usp reference standard, 4r,7r-n-1s,2s,4r,7s-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo 7.3.0.0^ 2,6 dodecan-4-yl-6-methyl-6,11-diazatetracyclo 7.6.1.0^ 2,7 .0^ 12,16 hexadeca-1 15 ,9,12 16 ,13-tetraene-4-carboxamide; methanesulfonic acid, 6ar,9r-n-2r,5s,10as,10bs-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8h-oxazolo 3,2-a pyrrolo 2,1-c pyrazin-2-yl-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo 4,3-fg quinoline-9-carboxamide methanesulfonate
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid

Specifications

6190-39-2
C34H41N5O8S
100 mg
ADYPXRFPBQGGAH-UMYZUSPBSA-N
(2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboxamide; methanesulfonic acid
6420006
≥97.0% (HPLC)
Dihydroergotamine Mesylate
Red-Yellow
MFCD00058615
dihydroergotamine mesylate, dihydroergotamine methanesulfonate salt, dihydroergotoxine, prestwick_746, dihydroergotamine methanesulfonate salt, powder, dihydroergotamine mesilate, european pharmacopoeia ep reference standard, dihydroergotamine for peak identification, european pharmacopoeia ep reference standard, dihydroergotamine mesylate, united states pharmacopeia usp reference standard, 4r,7r-n-1s,2s,4r,7s-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo 7.3.0.0^ 2,6 dodecan-4-yl-6-methyl-6,11-diazatetracyclo 7.6.1.0^ 2,7 .0^ 12,16 hexadeca-1 15 ,9,12 16 ,13-tetraene-4-carboxamide; methanesulfonic acid, 6ar,9r-n-2r,5s,10as,10bs-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxooctahydro-8h-oxazolo 3,2-a pyrrolo 2,1-c pyrazin-2-yl-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo 4,3-fg quinoline-9-carboxamide methanesulfonate
CS(O)(=O)=O.CN1C[C@@H](C[C@H]2[C@H]1CC1=CNC3=CC=CC2=C13)C(=O)N[C@]1(C)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](CC3=CC=CC=C3)N2C1=O
679.79
679.79
Crystalline Powder
Videos
Safety and Handling

Safety and Handling

RTECSNumber : KE7920000

TSCA : No

SDS
missing translation for 'documents'

missing translation for 'documents'